The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-01-31

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the general anesthesia immunosuppressive could effect hepatitis B Virus replication

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

NCT02601040

Hepatitis A

COMPLETED PHASE4

Evaluation of Immunoprotection Provided by Hepatitis B Vaccine After Birth in Healthy Children

NCT04439435

Vaccine Reaction

UNKNOWN

Efficacy of Hepatitis B Vaccine Boosters Among Neonatally Vaccinated Children in Chongqing

NCT03867643

Hepatitis B Vaccine Adverse Reaction

RECRUITING

Study the Content of the HBV DNA in Liver Biopsy in the Patients Chronic Hepatitis Delta

NCT04170452

Chronic Hepatitis Delta Liver Biopsy

UNKNOWN

Comparative Immunogenicity Study of Two Hepatitis A Vaccines

NCT03231605

Hepatitis A

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The change of immune state can influence HBV replication or elimination, it has been reported that a certain degree of immunosuppression occured after general anesthesia. In this study we detect the cytotoxic T lymphocyte(CTL) count and activity, interferon-γ(IFN-γ) and HBV-DNA content form the HBV patient who will accept general anesthesia. Our purpose is to evaluate the influence of general anesthesia immunosuppressive on HBV replication. If the results show that HBV-DNA quantity increases, so the patients might be given anti-HBV drugs or immune enhancer; otherwise it is indicated the general anesthesia immunosuppressive don't influence HBV replication.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HBV Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

intravenous inhalational anesthesia

No interventions assigned to this group

B

intravenous anesthesia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. American Society of Anesthesiologists（ASA） Ⅰ - Ⅱ;
2. ability to compliance the research plan;
3. volunteered and signed for the study ;
4. HBsAg positive, no serious system disease (heart: New York Heart Association（NYHA） class Ⅰ - Ⅱ, lung: vital capacity（VC）% or maximal voluntary ventilation（MVV）%\>71, forced expiratory volume at one second（FEV1.0）%\>61, arterial oxygen saturation（SaO2）%\>94, arterial partial pressure of oxygen（PaO2）\>75 mmHg, arterial carbondioxide partial pressure（PaCO2）\<45mmHg, liver:child-pugh class A - B and kidney: chronic kidney disease（CKD）stage 1-3);
5. receive under general anesthesia (including gynecology, orthopedics,general surgery and urology department).